Darmon, P <br/><br/>
Options for intensification of basal insulin in type 2 diabetes: Premeal insulin or short-acting GLP-1 receptor agonists?  [electronic resource] 

 -  Diabetes & metabolism  Dec 2015 
 - 6S21-6S27 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1878-1780 
<br/><br/><label>Standard No.: </label>10.1016/S1262-3636(16)30005-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Blood Glucose--drug effects<br/>Diabetes Mellitus, Type 2--blood<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Exenatide<br/>Humans<br/>Hypoglycemic Agents--administration & dosage<br/>Insulin--administration & dosage<br/>Meals<br/>Peptides--administration & dosage<br/>Randomized Controlled Trials as Topic<br/>Venoms--administration & dosage<br/>Glucagon-Like Peptide-1 Receptor Agonists